GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone

Hypertension

Volumn 57, Issue 3, 2011, Pages 442-451

  Gros, Robert ^a,b,c   Ding, Qingming ^c   Sklar, Larry A ^d   Prossnitz, Eric E ^e   Arterburn, Jeffrey B ^f   Chorazyczewski, Jozef ^c   Feldman, Ross D ^a,b,c  

^a Departments of Medicine   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

aldosterone; apoptosis; ERK; GPR30; vascular smooth muscle

Indexed keywords

ALDOSTERONE; CORTICOSTERONE; G PROTEIN COUPLED RECEPTOR 30; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL CULTURE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALDOSTERONE; ANALYSIS OF VARIANCE; ANIMALS; AORTA; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CORTICOSTERONE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RATS; RATS, INBRED WKY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION;

EID: 79953235261     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.161653     Document Type: Article

References (35)

1. Pietras RJ, Szego CM. Endometrial cell calcium and oestrogen action. Nature. 1975;253:357-359.
2. Streeten DH, Hirschowitz BI, Henley KS, Pollard HM. Effects of adrenocortical steroids on the propulsive motility of small intestine. Am J Physiol. 1957;189:108-112.
3. Szego CM, Davis JS. Adenosine 3,5-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA. 1967;58:1711-1718.
4. Pietras RJ, Szego CM. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977;265:69-72. (Pubitemid 8004314)
5. Funder JW. Minireview: Aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology. 2006;147:5564-5567. (Pubitemid 44833472)
6. Wehling M, Spes CH, Win N, Janson CP, Schmidt BM, Theisen K, Christ M. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab. 1998;83:3517-3522. (Pubitemid 28500882)
7. Meyer MR, Haas E, Prossnitz ER, Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. 2009;308:9-16.
8. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103: 401-406. (Pubitemid 29069990)
9. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol. 2002;90:3F- 6F. (Pubitemid 34775144)
10. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60:210-241. (Pubitemid 351962010)
11. Bunda S, Wang Y, Mitts TF, Liu P, Arab S, Arabkhari M, Hinek A. Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase/Akt. J Biol Chem. 2009;284:16633-16647.
12. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics. 1997;45:607-617. (Pubitemid 27506136)
13. Ding Q, Gros R, Limbird LE, Chorazyczewski J, Feldman RD. Estradiolmediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am J Physiol Cell Physiol. 2009;297: C1178-C1187.
14. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625-1630. (Pubitemid 40354745)
15. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002;80:231-238. (Pubitemid 34233742)
16. Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab. 2005;16: 362-367. (Pubitemid 41338741)
17. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Ando S, Maggiolini M. 17Beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol. 2006; 70:1414-1423. (Pubitemid 44435994)
18. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007;148:3236-3245. (Pubitemid 46997004)
19. Wang C, Dehghani B, Magrisso IJ, Rick EA, Bonhomme E, Cody DB, Elenich LA, Subramanian S, Murphy SJ, Kelly MJ, Rosenbaum JS, Vandenbark AA, Offner H. GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol. 2008;22:636-648. (Pubitemid 351397791)
20. Revankar CM, Mitchell HD, Field AS, Burai R, Corona C, Ramesh C, Sklar LA, Arterburn JB, Prossnitz ER. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem Biol. 2007;2:536-544. (Pubitemid 350011324)
21. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 2008;70:165-190. (Pubitemid 351738176)
22. Olde B, Leeb-Lundberg LM. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab. 2009;20:409-416.
23. Gros R, Ding Q, Armstrong S, O'Neil C, Pickering JG, Feldman RD. Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am J Physiol Cell Physiol. 2007;292:C788-C794.
24. Gros R, Ding Q, Chorazyczewski J, Pickering JG, Limbird LE, Feldman RD. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization. Circ Res. 2006;99: 845-852. (Pubitemid 44556383)
25. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5:421-427.
26. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;237:268-275. (Pubitemid 17095145)
27. Liu SL, Schmuck S, Chorazcyzewski JZ, Gros R, Feldman RD. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation. 2003;108:2400-2406. (Pubitemid 37413549)
28. Sheppard KE, Funder JW. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies. J Steroid Biochem. 1987;28:737-742. (Pubitemid 18047931)
29. Molnar GA, Lindschau C, Dubrovska G, Mertens PR, Kirsch T, Quinkler M, Gollasch M, Wresche S, Luft FC, Muller DN, Fiebeler A. Glucocorticoid-related signaling effects in vascular smooth muscle cells. Hypertension. 2008;51:1372-1378. (Pubitemid 351555952)
30. Yang G, Wu L, Wang R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J. 2006;20:553-555. (Pubitemid 46671247)
31. Vantler M, Caglayan E, Zimmermann WH, Baumer AT, Rosenkranz S. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3-kinase is important. J Biol Chem. 2005;280:14168-14176. (Pubitemid 40517319)
32. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624-632. (Pubitemid 40129818)
33. Feng Y, Gregor P. Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem Biophys Res Commun. 1997;231:651-654. (Pubitemid 27217571)
34. Rubanyi GM, Kauser K, Johns A. Role of estrogen receptors in the vascular system. Vasc Pharmacol. 2002;38:81-88. (Pubitemid 36401586)
35. McManus F, McInnes GT, Connell JM. Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist. Nat Clin Pract Endocrinol Metab. 2008;4:44-52. (Pubitemid 350291101)